e4life, a joint venture formed by two global leaders—ELT Group, a world leader in electronic defense, and Lendlease, experts in large-scale urban regeneration—will present its e4shield™ technology at MEDICA 2024.…
Inquis Medical, an innovator in advanced thrombectomy systems, today announced the successful closure of its oversubscribed $40 million Series B financing round. The round was led by Marshall Wace, a…
Cardinal Health (NYSE: CAH) reported its first-quarter fiscal year 2025 revenue at $52.3 billion, a 4% decline compared to the same quarter in fiscal year 2024. Excluding the impact of…
Centene Corporation (NYSE: CNC), a prominent healthcare enterprise dedicated to improving lives, announced that its subsidiary, Buckeye Health Plan, has been selected by the Ohio Department of Medicaid (ODM) to…
Innovive, LLC, a leader in disposable caging and preclinical research solutions, has announced a change in its executive leadership with the appointment of Jamie S. Blose, Pharm.D., MBA, JD, as…
BlueWind Medical, Ltd., a leader in implantable Tibial Neuromodulation (iTNM) and the developer of the Revi® System for urge urinary incontinence (UUI), has announced the publication of a comprehensive meta-analysis…
NeuroIntact Inc., a leader in targeted temperature management (TTM) for stroke and traumatic brain injury, has appointed Robert Kline to its Board of Directors. With 25 years of experience in…
Egnite, Inc., a leading cardiovascular digital health company, has announced significant findings from its research on the real-world effects of clinical presentation in patients with moderate or greater aortic stenosis…
Late-breaking results from the CONFIRM2 global multicenter study were presented today at the Transcatheter Cardiovascular Therapeutics (TCT) 2024 conference. The study highlighted how a non-invasive, comprehensive AI-based analysis of cardiac…
Alcon, a global leader in eye care committed to helping people see brilliantly, has been named one of the ‘Best Employers in Singapore’ for the second consecutive year, following its…
Elucid has announced that Noridian will begin covering AI-enabled quantitative coronary plaque analysis, including its FDA-cleared PlaqueIQ™ image analysis software, starting December 8, 2024. With this decision, five out of…
WellSky, a prominent technology company in health and community care, has announced its acquisition of Bonafide, a software solution designed for durable medical equipment (DME) and home medical equipment (HME)…
